It will be interesting to see who the new global funds are that have invested ... Up to $30,000 for current shareholders so 20,000 maximum shares, which is more than the usual $15,000 worth
GLTAH
Share Purchase Plan
Starpharma will offer all eligible shareholders the opportunity to subscribe up to a maximum of A$30,000 of shares at the same Placement price of A$1.50 per share without incurring brokerage costs. Shareholders on the Starpharma register at 7.00pm (Melbourne time) on 29 September 2020 (the record date) with a registered address in Australia or New Zealand will be entitled to subscribe for up to A$30,000 worth of shares through the SPP. The Company reserves the right to accept oversubscriptions or scale back as appropriate.
SPL Price at posting:
$1.61 Sentiment: Hold Disclosure: Held
... Up to $30,000 for current shareholders so 20,000 maximum shares, which is more than the usual $15,000 worth
